LibraMedicina has been recognized as a
“2023 Top Pharmaceutical Outsourcing Service Provider in the Asia Pacific Region”
We are pleased to announce that LibraMedicina has been recognized as a “2023 Top Pharmaceutical Outsourcing Service Provider in the Asia Pacific Region” by Pharma Tech Outlook’s Life Science magazine, with a global readership. This prestigious accolade reflects our commitment to facilitating seamless collaborations between pharmaceutical and food-related company sponsors and our esteemed partner contract companies (CRO/CDMO). Our unwavering dedication to optimizing development operations has earned us this recognition, underscoring the high regard in which our efforts have been held.
Building upon the honor of this prestigious award, we remain steadfast in leveraging our vast experience and expertise to facilitate contract engagements spanning the development and manufacturing of biopharmaceuticals, fermentation products, and licenses for pharmaceuticals and medical devices. Our commitment extends beyond mere provision; we are dedicated to actively contributing to the advancement of the industry. Should you have any inquiries regarding outsourcing or licensing in pharmaceutical and food development, we encourage you to reach out to us. We stand ready to provide assistance and insights tailored to your needs.
